What are the side effects of mavacamten?

Mavacamten (mavacamten) is a new cardiac myosin inhibitor used to treat obstructive hypertrophic cardiomyopathy (HCM). Although the drug has shown good clinical efficacy, as with any drug, the use of Mavaceta may be associated with some side effects and risks.

Common adverse reactions include dizziness and syncope. These symptoms are often related to the drug's effect on heart function, which may cause the patient to feel dizzy or lose balance, especially when standing up or changing position. Therefore, patients should pay special attention to observing their body's reactions after starting to use Mavacartide and avoid doing things that require high concentration or extensive physical activity until tolerance to the drug is confirmed.

In addition, taking Mavacartide may increase the risk of heart failure. The drug works by regulating the contraction of the heart muscle, but in some cases, especially at higher doses or in patients with poor underlying heart function, it may cause a decrease in heart function. Therefore, all patients need to regularly monitor their heart function during treatment, and doctors will adjust the treatment plan according to the patient's specific situation to reduce the risk of heart failure.

Interactions with other medications are also an important consideration when using Mavakate. Certain medications may increase or decrease the effects of mavacartide, which may lead to heart failure or the drug becoming ineffective. Therefore, patients should inform their doctors about all the medications they are taking, including prescription drugs, over-the-counter drugs, and herbal supplements, before starting any new medications to ensure there are no potential negative interactions between the drugs.

In addition, Mavakate also carries the risk of embryo-fetal toxicity, so pregnant women or female patients planning to become pregnant should use this drug with extreme caution. During treatment, women should use effective contraception and discuss possible risks and alternative treatment options with their doctor.

Reference materials:https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=669c936b-3ee6-4e36-8a22-79dd11b1255b##